Health
BioNTech/Pfizer Vaccination Analysis Confirms High Overall Efficacy – Clinical OMICs News
Results from an analysis of COVID-19 vaccination data from Israel show over 90% protection from SARS-CoV-2 infection with the BioNTech/Pfizer vaccine. However,…
Results from an analysis of COVID-19 vaccination data from Israel, where most of the population have now been vaccinated, confirm earlier Phase III data and show over 90% protection from asymptomatic and symptomatic disease with the BioNTech/Pfizer vaccine.
Notably, this efficacy held true despite several variants of concern circulating in Israel at the time of vaccination, with the UK B.1.1.7 variant being the most common. While efficacy was good, there was a decrease in efficacy in much older…
-
Noosa News19 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News17 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General21 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News24 hours agoTips to improve engagement – Proctor